Morning Briefing
Summaries of health policy coverage from major news organizations
Clinical Trial Reveals Cholera Vaccine Is Safe, Offers Protection For Up To 2 Years
A clinical trial of an Indian-made "modified killed-whole-cell" oral cholera vaccine "that meets WHO standards" has found that the vaccine is safe and effective in children living in parts of India where the disease is endemic, Reuters reports. The researchers, who reported their findings in the Lancet, hope to soon introduce the vaccine into other cholera endemic settings.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
